These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 18197805)

  • 1. Targeting OX40 and OX40L for the treatment of autoimmunity and cancer.
    Redmond WL; Weinberg AD
    Crit Rev Immunol; 2007; 27(5):415-36. PubMed ID: 18197805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OX40, OX40L and Autoimmunity: a Comprehensive Review.
    Webb GJ; Hirschfield GM; Lane PJ
    Clin Rev Allergy Immunol; 2016 Jun; 50(3):312-32. PubMed ID: 26215166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OX40/OX40L axis: not a friend in autoimmunity.
    Ueno H; Blanco P
    Oncotarget; 2015 Sep; 6(26):21779-80. PubMed ID: 26314852
    [No Abstract]   [Full Text] [Related]  

  • 4. OX40 (CD134) and OX40L.
    Gough MJ; Weinberg AD
    Adv Exp Med Biol; 2009; 647():94-107. PubMed ID: 19760068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OX40L/OX40 axis impairs follicular and natural Treg function in human SLE.
    Jacquemin C; Augusto JF; Scherlinger M; Gensous N; Forcade E; Douchet I; Levionnois E; Richez C; Lazaro E; Duffau P; Truchetet ME; Seneschal J; Couzi L; Pellegrin JL; Viallard JF; Schaeverbeke T; Pascual V; Contin-Bordes C; Blanco P
    JCI Insight; 2018 Dec; 3(24):. PubMed ID: 30568041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Requirements for the functional expression of OX40 ligand on human activated CD4+ and CD8+ T cells.
    Kondo K; Okuma K; Tanaka R; Zhang LF; Kodama A; Takahashi Y; Yamamoto N; Ansari AA; Tanaka Y
    Hum Immunol; 2007 Jul; 68(7):563-71. PubMed ID: 17584577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of OX40-mediated co-stimulation in T-cell activation and survival.
    Redmond WL; Ruby CE; Weinberg AD
    Crit Rev Immunol; 2009; 29(3):187-201. PubMed ID: 19538134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The OX40/OX40L Axis Regulates T Follicular Helper Cell Differentiation: Implications for Autoimmune Diseases.
    Fu N; Xie F; Sun Z; Wang Q
    Front Immunol; 2021; 12():670637. PubMed ID: 34234777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OX40-OX40 ligand interaction in T-cell-mediated immunity and immunopathology.
    Ishii N; Takahashi T; Soroosh P; Sugamura K
    Adv Immunol; 2010; 105():63-98. PubMed ID: 20510730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent Immune Modulation by MEDI6383, an Engineered Human OX40 Ligand IgG4P Fc Fusion Protein.
    Oberst MD; Augé C; Morris C; Kentner S; Mulgrew K; McGlinchey K; Hair J; Hanabuchi S; Du Q; Damschroder M; Feng H; Eck S; Buss N; de Haan L; Pierce AJ; Park H; Sylwester A; Axthelm MK; Picker L; Morris NP; Weinberg A; Hammond SA
    Mol Cancer Ther; 2018 May; 17(5):1024-1038. PubMed ID: 29545330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of OX40 ligand/OX40 axis signalling in atopic dermatitis.
    Guttman-Yassky E; Croft M; Geng B; Rynkiewicz N; Lucchesi D; Peakman M; van Krinks C; Valdecantos W; Xing H; Weidinger S
    Br J Dermatol; 2024 Sep; 191(4):488-496. PubMed ID: 38836560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of OX40 (CD134) in T-cell memory generation.
    Weinberg AD
    Adv Exp Med Biol; 2010; 684():57-68. PubMed ID: 20795540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of immunity by the TNFR-related molecule OX40 (CD134).
    Croft M
    Annu Rev Immunol; 2010; 28():57-78. PubMed ID: 20307208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central Roles of OX40L-OX40 Interaction in the Induction and Progression of Human T Cell-Driven Acute Graft-versus-Host Disease.
    Tripathi T; Yin W; Xue Y; Zurawski S; Fujita H; Hanabuchi S; Liu YJ; Oh S; Joo H
    Immunohorizons; 2019 Mar; 3(3):110-120. PubMed ID: 31240276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OX40 Ligand Contributes to Human Lupus Pathogenesis by Promoting T Follicular Helper Response.
    Jacquemin C; Schmitt N; Contin-Bordes C; Liu Y; Narayanan P; Seneschal J; Maurouard T; Dougall D; Davizon ES; Dumortier H; Douchet I; Raffray L; Richez C; Lazaro E; Duffau P; Truchetet ME; Khoryati L; Mercié P; Couzi L; Merville P; Schaeverbeke T; Viallard JF; Pellegrin JL; Moreau JF; Muller S; Zurawski S; Coffman RL; Pascual V; Ueno H; Blanco P
    Immunity; 2015 Jun; 42(6):1159-70. PubMed ID: 26070486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of CD4(+) T cell response and survival via coexpressed OX40/OX40L in Graves' disease.
    Wang Q; Shi BM; Xie F; Fu ZY; Chen YJ; An JN; Ma Y; Liu CP; Zhang XK; Zhang XG
    Mol Cell Endocrinol; 2016 Jul; 430():115-24. PubMed ID: 27107937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OX40:OX40L axis: emerging targets for improving poxvirus-based CD8(+) T-cell vaccines against respiratory viruses.
    Goulding J; Tahiliani V; Salek-Ardakani S
    Immunol Rev; 2011 Nov; 244(1):149-68. PubMed ID: 22017437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. OX40 signaling is involved in the autoactivation of CD4
    Jiang J; Liu C; Liu M; Shen Y; Hu X; Wang Q; Wu J; Wu M; Fang Q; Zhang X
    Arthritis Res Ther; 2017 Mar; 19(1):67. PubMed ID: 28320444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Immune Checkpoint Modulator OX40 and Its Ligand OX40L in NK-Cell Immunosurveillance and Acute Myeloid Leukemia.
    Nuebling T; Schumacher CE; Hofmann M; Hagelstein I; Schmiedel BJ; Maurer S; Federmann B; Rothfelder K; Roerden M; Dörfel D; Schneider P; Jung G; Salih HR
    Cancer Immunol Res; 2018 Feb; 6(2):209-221. PubMed ID: 29321210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OX40 signaling directly triggers the antitumor effects of NKT cells.
    Zhou D
    J Clin Invest; 2007 Nov; 117(11):3169-72. PubMed ID: 17975660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.